VBWG
Slides

Redefining Treatment Strategies for Optimal Medical Care in CAD: COURAGE and MERLIN-TIMI 36 Trials



Redefining Treatment Strategies for Optimal Medical Care in CAD

Download VBWG07_COURAGE_MERLIN.ppt (28 slides - 0.8MB)

Redefining Treatment Strategies for Optimal Medical Care in CAD COURAGE COURAGE: Background and objective COURAGE: Study design Lifestyle intervention and risk factor goals Pharmacologic therapy COURAGE: Baseline demographics COURAGE: Baseline angiographic data COURAGE: Baseline angina COURAGE: Inducible ischemia at baseline COURAGE: Change in lifestyle factors COURAGE: Improvement in CV risk factors Angiographic outcomes COURAGE: Treatment effect on primary outcome COURAGE: Treatment effects COURAGE: Treatment effect on hospitalization for ACS COURAGE: Treatment effect on angina Treatment effect in CV and diabetes subgroups COURAGE: Summary and implications MERLIN-TIMI 36 MERLIN-TIMI 36: Background MERLIN-TIMI 36: Objective MERLIN-TIMI 36: Study design MERLIN-TIMI 36: Effect on primary endpoint MERLIN-TIMI 36: Effect on efficacy outcomes MERLIN-TIMI 36: Major safety outcomes MERLIN-TIMI 36: Summary and implications COURAGE, MERLIN-TIMI 36: Optimal medical therapy for patients with CAD

Click to view Contemporary Management of Myocardial Ischemia Slide Lecture Program (WITH 119 SLIDES)

CADCOURAGEMERLINRedefiningTIMI

Related at vwbg.org

Core Curriculum

Myocardial Ischemia Redefined: Optimal Care in CAD

View/Download individual slides (90 Slides)

ExTRACT-TIMI 25 study

Results from ExTRACT-TIMI 25: The Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis in Myocardial Infarction Study 25

Vascular Biology in Clinical Practice © Vol. 7, No. 1

ACE Inhibition in CAD Patients: Expanding the Reach of Cardioprotection

This monograph, ACE Inhibition in CAD Patients: Expanding the Reach of Cardioprotection , which is being offered as part of a series of continuing medical education activities from the University of Florida College of Medicine.
More related